Inactive Instrument

Protea Biosciences Group Inc Stock OTC Bulletin Board

US74365B1098

Healthcare Facilities & Services

Latest news : Protea Biosciences Group Inc

18-07-25	Summit Resources Inc cancelled the acquisition of all assets of Protea Biosciences Group, Inc (OTCPK:PRGB.Q).	CI
18-02-01	Protea Biosciences, Inc. Emerged from Bankruptcy	CI
18-01-25	Motion for Asset Sale Approved for Protea Biosciences, Inc.	CI
18-01-19	Final DIP Financing Approved for Protea Biosciences, Inc.	CI
17-12-13	Bidding Procedure Approved for Protea Biosciences, Inc.	CI
17-12-12	Interim DIP Financing Approved for Protea Biosciences, Inc.	CI
17-12-05	Protea Biosciences Group, Inc Announces the Resignation of David Halverson as President	CI
17-12-05	Motion for Asset Sale Filed by Protea Biosciences, Inc.	CI
17-12-04	Motion for Joint Administration Approved for Protea Biosciences, Inc.	CI
17-12-04	Summit Resources Inc entered into asset purchase agreement to acquire all assets of Protea Biosciences Group, Inc (OTCPK:PRGB.Q) for $1.3 million.	CI
17-12-01	Protea Biosciences, Inc. Announces Resignation of Patrick Gallagher as Member of the Board	CI
17-12-01	Motion for Joint Administration Filed by Protea Biosciences, Inc.	CI
17-11-30	Protea Biosciences, Inc. Filed for Bankruptcy	CI

More news

Medical & Diagnostic Laboratories

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PROTEA BIOSCIENCES GROUP INC	+2.00%	-47.37%	-	-	803
NATERA, INC.	+21.37%	+20.29%	+111.98%	+516.46%	46.43B
LABCORP HOLDINGS INC.	+0.83%	+3.22%	+20.06%	+47.61%	25.88B
SONIC HEALTHCARE LIMITED	+0.67%	+2.56%	-18.72%	-34.64%	7.76B
RADNET, INC.	+6.20%	+13.49%	+35.65%	+129.72%	5.69B
DR. LAL PATHLABS LIMITED	+0.98%	+2.56%	+21.09%	+65.13%	3.39B
GENEDX HOLDINGS CORP.	+10.76%	+18.38%	-26.68%	+1,226.68%	2.3B
NEOGENOMICS, INC.	+6.49%	+8.37%	+185.69%	+11.81%	2.13B
FLEURY S.A.	+11.67%	+10.56%	+32.06%	+23.61%	2.02B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	+3.35%	+4.36%	-4.07%	-56.01%	1.99B
Average	+6.42%	+9.20%	+39.67%	+214.49%	10.84B
Weighted average by Cap.	+11.54%	+12.43%	+63.91%	+293.88%

See all sector performances

Protea Biosciences Group, Inc. is a molecular information company. The Company is engaged in developing and commercializing life science technologies, products and services to identify the molecules that are produced by living cells and all life forms. It also offers a platform technology, Laser Ablation Electrospray Ionization (LAESI), which enables the direct analysis, mapping and display of molecular information in living cells and tissue samples. The Company's commercial development is centered in three business lines: Molecular Information Services, LAESI Instruments, Software and Consumables, and Molecular Diagnostics and Clinical Research. Its services enable the identification and quantitation of both small molecules (lipids and metabolites) and large molecules (proteins) and the services portfolio, inclusive of mass spectrometry imaging (MSI), proteomics, metabolomics, lipidomics and bioinformatics. Its clients include pharmaceutical, chemical and biotechnology companies.

Employees

Sector

Healthcare Facilities & Services

More about the company